Deyi Zhang Email & Phone Number | Complex API expert in the Office of Generic Drugs providing scientific support for regulatory policy development and generic drug product-specific guidance development. Prior to joining FDA, served in different capacities as a drug hunter in pharmaceutical industry for 15 years. Specialties: Complex API Characterization, Generic Drugs Development, Regulatory Science, Medicinal Chemistry, Synthetic Organic Chemistry, Neuroscience, Pain and Migraine, Obesity, Psychiatric Disorders, Ion Channel, Cell Surface Receptors, GPCR, Endocannabinoid System, Cancer, Osteoarthritis, Inflammation, Oncology, Kinase Inhibitors, Drug Design

Deyi Zhang

Complex API expert in the Office of Generic Drugs providing scientific support for regulatory policy...
Washington Dc, Washington Dc, United States

*50 free lookup(s) per month.

Deyi Zhang’s Email deyi.zhang@fda.gov

Deyi Zhang’s Phone Numbers

Get DEYI’s Phone Number (For Free)

Social Media

Deyi Zhang’s Location Washington Dc, Washington Dc, United States

Deyi Zhang’s Current Industry Fda

Deyi Zhang’s Prior Industry Crownbio | Eli Lilly | University Of Pennsylvania

Find accurate emails & phone numbers for over 700M professionals.

Senior Chemist

2018-10-01 00:00:00 - Present

Executive Director

2013-01-01 00:00:00 - 2015-01-01 00:00:00

Principal Research Scientist

2000-07-01 00:00:00 - 2010-06-01 00:00:00

Post doc

1998-01-01 00:00:00 - 2000-01-01 00:00:00

No Skills Available

No Languages Available

Deyi Zhang is a Complex API expert in the Office of Generic Drugs providing scientific support for regulatory policy development and generic drug product-specific guidance development. Prior to joining FDA, served in different capacities as a drug hunter in pharmaceutical industry for 15 years. Specialties: Complex API Characterization, Generic Drugs Development, Regulatory Science, Medicinal Chemistry, Synthetic Organic Chemistry, Neuroscience, Pain and Migraine, Obesity, Psychiatric Disorders, Ion Channel, Cell Surface Receptors, GPCR, Endocannabinoid System, Cancer, Osteoarthritis, Inflammation, Oncology, Kinase Inhibitors, Drug Design